The lawsuit that kicked off all the Valeant drama has been settled

Valeant Pharmaceuticals has settled its lawsuit with R&O Pharmacy, a pharmacy that was once a part of the drug maker’s specialty pharmacy network.

It was this lawsuit, when uncovered by short seller Andrew Left of Citron Research, that set off a fire storm for Valeant and sent its stock crashing.

The lawsuit forced the company to reveal that it had a secret network of pharmacies pushing its products around the country.

Valeant put the following statement about the settlement on its website:

LAVAL, Quebec, March 9, 2016 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and R&O Pharmacy, LLC (R&O) today announced that they have jointly requested the Court to dismiss the litigation between them pursuant to a confidential settlement agreement that resolves all claims between them. While the terms of the settlement are confidential, the resolution includes a payment by R&O to Valeant. As noted at the onset of the matter, Valeant firmly believes it acted appropriately and refutes any suggestion of wrongdoing.

More to come…

NOW WATCH: This is how rapper 50 Cent made millions and then lost it

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.